Shane Gaylor brings a diverse finance background to Innocura, with experience spanning healthcare, technology, high-growth companies, and public-company environments. His career has centered on helping organizations build stronger financial foundations, navigate complex transactions, and turn financial information into actionable insight for executive and operational leaders.

Before joining Innocura, Shane led finance for Aspen Pediatrics and later served as Senior Director of Finance with U.S. Pediatric Partners following its acquisition of the organization. At Aspen, Shane served as a strategic finance partner to executive leadership, helping shape the organization’s growth strategy, strengthen financial performance, and build the infrastructure needed to scale. He played a central role in the company’s acquisition strategy, leading financial analysis and diligence across multiple physician practice transactions, and later helped lead the sell-side financial process culminating in Aspen’s acquisition by U.S. Pediatric Partners. Following the transaction, Shane took on an expanded role within the combined organization, leading the financial integration of the Maryland region and partnering with corporate leadership on enterprise-wide forecasting and strategic finance initiatives.

Earlier in his career, Shane held finance leadership roles with high-growth technology companies, where he built finance functions, supported capital raises and M&A, and led financial transformation initiatives. He began his career with Ernst & Young, serving public-company clients in assurance and financial reporting.

Shane earned his Bachelor of Science in Business Administration with a major in Accounting from Oklahoma State University.